Skip to content

A multicenter, observational study on the efficacy of lubiprostone in the treatment of adult chronic constipation in an ethnic region

A multicenter, observational study on the efficacy of lubiprostone in the treatment of adult chronic constipation in an ethnic region

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094843
Enrollment
Unknown
Registered
2024-12-30
Start date
2024-12-30
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic constipation

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Informed consent voluntarily signed by the subject; 2. Male or female, aged >=18 years old; 3. Meets the Rome IV criteria for functional constipation (FC): Must include two or more of the following: > 25% of the feces feel laborious; >25% of the feces are dry or hard; > 25% of fecal defecation has a feeling of incompleteness; >25% of feces have an anorectal obstruction (or blockage) sensation; >25% of fecal excretions require manual assistance; Spontaneous fecal defecation =75 years old, subjects who meet the above 2-5 inclusion conditions, and their guardians voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Unwillingness to sign informed consent; 2.Those with a prior history of rupiprostenone use; 3.Hypersensitivity to rupiprostenone and its excipients or corkscrew (containing glycerin); 4.Those with a history or significant clinical presentation of mechanical intestinal obstruction (e.g., intestinal tumor or hernia-induced intestinal obstruction); 5.Those with megalorectal/megacolon or pseudo-obstruction; 6.Patients with intestinal tumors; 7.Pregnant and lactating patients; 8.Patients with abnormal liver function and severe renal impairment; 9.Other conditions deemed inappropriate for enrollment by the investigator.

Design outcomes

Primary

MeasureTime frame
Number of spontaneous bowel movements (SBM);

Countries

China

Contacts

Public ContactYang Hongju

The First Affiliated Hospital of Kunming Medical University

1379702184@qq.com+86 13888213607

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026